Lyell Immunopharma (LYEL) Asset Utilization Ratio: 2021-2025
Historic Asset Utilization Ratio for Lyell Immunopharma (LYEL) over the last 4 years, with Sep 2025 value amounting to 0.00.
- Lyell Immunopharma's Asset Utilization Ratio rose 4.45% to 0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.00, marking a year-over-year increase of 4.45%. This contributed to the annual value of 0.00 for FY2024, which is 36.19% down from last year.
- Lyell Immunopharma's Asset Utilization Ratio amounted to 0.00 in Q3 2025, which was down 29.79% from 0.00 recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Asset Utilization Ratio registered a high of 0.09 during Q1 2023, and its lowest value of 0.00 during Q2 2024.
- Over the past 3 years, Lyell Immunopharma's median Asset Utilization Ratio value was 0.00 (recorded in 2025), while the average stood at 0.02.
- Per our database at Business Quant, Lyell Immunopharma's Asset Utilization Ratio skyrocketed by 1,063.08% in 2023 and then crashed by 99.90% in 2024.
- Lyell Immunopharma's Asset Utilization Ratio (Quarterly) stood at 0.01 in 2021, then soared by 865.78% to 0.09 in 2022, then slumped by 99.81% to 0.00 in 2023, then slumped by 34.69% to 0.00 in 2024, then rose by 4.45% to 0.00 in 2025.
- Its last three reported values are 0.00 in Q3 2025, 0.00 for Q2 2025, and 0.00 during Q1 2025.